| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | MADRIGAL PHARMACEUTICALS, INC. | 1,266,375 | 7.4% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | MADRIGAL PHARMACEUTICALS, INC. | 31,830 | 0.2% | EDGAR |
| SC 13G | 2023-02-02 | STATE STREET CORP | MADRIGAL PHARMACEUTICALS, INC. | - | 7.4% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | MADRIGAL PHARMACEUTICALS, INC. | 986,572 | 5.8% | EDGAR |
| SC 13G | 2022-05-19 | Deep Track Capital, LP | MADRIGAL PHARMACEUTICALS, INC. | 917,825 | 5.4% | EDGAR |
| SC 13G | 2022-02-15 | ARMISTICE CAPITAL, LLC | MADRIGAL PHARMACEUTICALS, INC. | 1,124,000 | 6.6% | EDGAR |
| SC 13G/A | 2022-02-14 | HealthCor Management, L.P. | MADRIGAL PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | MADRIGAL PHARMACEUTICALS, INC. | 1,425,000 | 8.3% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | MADRIGAL PHARMACEUTICALS, INC. | 1,123,061 | 6.6% | EDGAR |
| SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | MADRIGAL PHARMACEUTICALS, INC. | 1,320,795 | 7.7% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | MADRIGAL PHARMACEUTICALS, INC. | 949,527 | 5.6% | EDGAR |
| SC 13D/A | 2021-12-07 | BAY CITY CAPITAL LLC | MADRIGAL PHARMACEUTICALS, INC. | 2,037,140 | 11.9% | EDGAR |
| SC 13G/A | 2021-07-09 | Capital Research Global Investors | MADRIGAL PHARMACEUTICALS, INC. | 466,422 | 2.8% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | MADRIGAL PHARMACEUTICALS, INC. | 1,499,213 | 9.7% | EDGAR |
| SC 13G/A | 2021-02-16 | Capital Research Global Investors | MADRIGAL PHARMACEUTICALS, INC. | 1,890,787 | 12.2% | EDGAR |
| SC 13G/A | 2021-02-12 | HealthCor Management, L.P. | MADRIGAL PHARMACEUTICALS, INC. | 902,601 | 5.8% | EDGAR |
| SC 13G | 2021-02-12 | Avoro Capital Advisors LLC | MADRIGAL PHARMACEUTICALS, INC. | 1,225,000 | 7.9% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | MADRIGAL PHARMACEUTICALS, INC. | 888,418 | 5.7% | EDGAR |
| SC 13G/A | 2021-02-04 | WELLINGTON MANAGEMENT GROUP LLP | MADRIGAL PHARMACEUTICALS, INC. | 915,892 | 5.9% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | MADRIGAL PHARMACEUTICALS, INC. | 944,418 | 6.1% | EDGAR |